Metropolitan Life Insurance Company (MetLife)’s Cabot Corp CBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,857
Closed -$263K 375
2024
Q1
$263K Sell
2,857
-333
-10% -$27.1K 0.01% 616
2023
Q4
$266K Hold
3,190
0.01% 613
2023
Q3
$221K Buy
3,190
+140
+5% +$9.73K 0.01% 637
2023
Q2
$204K Buy
3,050
+48
+2% +$3.42K 0.01% 669
2023
Q1
$230K Sell
3,002
-416
-12% -$31.2K 0.01% 619
2022
Q4
$228K Buy
3,418
+143
+4% +$9.98K 0.01% 660
2022
Q3
$209K Sell
3,275
-157
-5% -$11.1K 0.01% 663
2022
Q2
$219K Hold
3,432
0.01% 662
2022
Q1
$235K Sell
3,432
-20,002
-85% -$1.32M 0.01% 741
2021
Q4
$1.32M Sell
23,434
-1,152
-5% -$63.3K 0.02% 780
2021
Q3
$1.23M Sell
24,586
-295
-1% -$15.8K 0.02% 808
2021
Q2
$1.42M Buy
24,881
+14,194
+133% +$834K 0.02% 742
2021
Q1
$560K Buy
10,687
+556
+5% +$27.4K 0.01% 1345
2020
Q4
$455K Sell
10,131
-248
-2% -$10.3K 0.01% 1418
2020
Q3
$374K Sell
10,379
-549
-5% -$20.9K 0.01% 1399
2020
Q2
$405K Sell
10,928
-4,228
-28% -$141K 0.01% 1366
2020
Q1
$396K Sell
15,156
-824
-5% -$31.4K 0.01% 1187
2019
Q4
$759K Sell
15,980
-125
-0.8% -$5.8K 0.01% 1071
2019
Q3
$730K Sell
16,105
-608
-4% -$26.2K 0.01% 1048
2019
Q2
$797K Sell
16,713
-271
-2% -$12.2K 0.01% 1028
2019
Q1
$707K Sell
16,984
-180
-1% -$8.1K 0.01% 1092
2018
Q4
$737K Sell
17,164
-382
-2% -$19K 0.01% 968
2018
Q3
$1.1M Sell
17,546
-250
-1% -$16.1K 0.02% 886
2018
Q2
$1.1M Hold
17,796
0.02% 872
2018
Q1
$992K Buy
17,796
+75
+0.4% +$4.73K 0.01% 902
2017
Q4
$1.09M Sell
17,721
-40,790
-70% -$2.45M 0.01% 847
2017
Q3
$3.27M Sell
58,511
-253
-0.4% -$13.5K 0.02% 787
2017
Q2
$3.14M Buy
58,764
+834
+1% +$45.8K 0.02% 807
2017
Q1
$3.47M Sell
57,930
-277
-0.5% -$15.8K 0.02% 760
2016
Q4
$2.94M Sell
58,207
-263
-0.4% -$13.5K 0.02% 821
2016
Q3
$3.06M Sell
58,470
-105
-0.2% -$5.2K 0.02% 788
2016
Q2
$2.67M Buy
58,575
+2,026
+4% +$94.4K 0.02% 827
2016
Q1
$2.73M Buy
56,549
+1,422
+3% +$61.2K 0.02% 787
2015
Q4
$2.25M Sell
55,127
-68
-0.1% -$2.69K 0.02% 854
2015
Q3
$1.74M Sell
55,195
-956
-2% -$33.1K 0.01% 966
2015
Q2
$2.09M Sell
56,151
-215
-0.4% -$9.28K 0.01% 954
2015
Q1
$2.54M Buy
56,366
+1,675
+3% +$74K 0.02% 809
2014
Q4
$2.4M Buy
54,691
+49
+0.1% +$2.21K 0.02% 899
2014
Q3
$2.77M Buy
54,642
+4,132
+8% +$227K 0.02% 799
2014
Q2
$2.93M Buy
50,510
+402
+0.8% +$23.4K 0.02% 816
2014
Q1
$2.96M Buy
50,108
+1,155
+2% +$60.5K 0.02% 789
2013
Q4
$2.52M Buy
48,953
+368
+0.8% +$17.4K 0.02% 852
2013
Q3
$2.08M Buy
48,585
+196
+0.4% +$7.91K 0.02% 907
2013
Q2
$1.81M Buy
+48,389
New +$1.8M 0.01% 937

Other funds holding CBT

Metropolitan Life Insurance Company (MetLife)'s CBT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cabot Corp (CBT) in Q2 2024, closing a stake of 2,857 shares — an estimated $263K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CBT in Q2 2013 and held it in 44 quarters. The position peaked at $3.47M in Q1 2017. 387 funds tracked by Wall St. Rank hold CBT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Cabot Corp position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,857 Cabot Corp shares in Q2 2024, an estimated $263K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Cabot Corp in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Cabot Corp position peaked at $3.47M in Q1 2017.
  • 387 funds tracked by Wall St. Rank held Cabot Corp as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.